查詢結果分析
相關文獻
- Metastatic Mucinous Colorectal Cancer: An Important Subtype of Colorectal Cancer with Poor Response to Chemotherapy and Overall Survival
- Treatment Results of Hodgkin's Disease from 1977 to 1991 in National Taiwan University Hospital
- 中晚期子宮頸癌放射線合併化學治療之近況
- Five-Year Survival Rate for Squamous Cell Carcinoma of the Anal Canal: A Retrospective Study
- Comparison of Weekly Vinorelbine and Weekly Docetaxel, Each with Cisplatin, for Locally Advanced Non-small Cell Lung Cancer in Patients with Concurrent Chemoradiotherapy
- 第二期大腸癌病人開刀後存活分析:著眼於化學治療--單一醫學中心的經驗
- Postoperative Concurrent Chemoradiotherapy for Non-Early Stage Gastric Adenocarcinoma
- 第二期大腸直腸癌是否需要化學治療?
- 淋巴癌概論
- 淋巴癌概論
頁籤選單縮合
題名 | Metastatic Mucinous Colorectal Cancer: An Important Subtype of Colorectal Cancer with Poor Response to Chemotherapy and Overall Survival=轉移性黏液型大腸直腸癌--重要的組織學子型可反映較差的化學治療效果以及預後 |
---|---|
作者 | 蘇祐立; 劉建廷; 邱泰然; 李劭軒; 黃泰霖; 陳彥仰; 唐曄; 饒坤銘; 黃承華; Su, Yu-li; Liu, Chien-ting; Chiu, Tai-jan; Li, Shan-hsuan; Huang, Tai-lin; Chen, Yen-yang; Tang, Yen; Rau, Kun-ming; Huang, Cheng-hua; |
期刊 | 臺灣癌症醫學雜誌 |
出版日期 | 20101200 |
卷期 | 26:6 2010.12[民99.12] |
頁次 | 頁221-230 |
分類號 | 416.245 |
語文 | eng |
關鍵詞 | 黏液型大腸直腸癌; 化學治療; 危險因子; 存活率; Mucinous colorectal cancer; Chemotherapy; Risk factor; Overall survival; |
中文摘要 | 背景:研究黏液型與非黏液型大腸直腸癌對於化學治療的反應以及存活率的差異。 病人及研究方法:我們回溯性分析29 名轉移性黏液型大腸直腸癌病人,以1:3 的比例找到87 名年紀,性別,及病理期別相符合的非黏液型大腸直腸癌病人。我們運用單變項及多變項分析方法,來找出對化學治療反應以及最終存活的相關因子。 結果:黏液型及非黏液型大腸直腸癌整體的化學治療反應率分別為33% 及58%(p=0.128)。在多變項分析去除各種可能干擾的因素後,黏液型大腸直腸癌是預測化療無效的獨立因子 (risk ratio, 0.15)。黏液型大腸直腸癌的中位存活期為8 個月,相較於非黏液型(20 個月)有較差的存活 (p=0.037)。在多變項分析中,黏液型仍是預後較差的獨立因子 (hazard ratio, 1.899, p=0.045)。 結論:相較於非黏液型大腸直腸癌,轉移性黏液型大腸直腸癌對化學治療反應較差,整體存活期也明顯短於非黏液型。 |
英文摘要 | Background: The purpose of this study was to investigate the specificity of metastatic mucinous colorectal cancer in terms of chemotherapy response and overall survival compared with non-mucinous colorectal adenocarcinoma. Methods: Twenty-nine mucinous-type and eighty-seven non-mucinous colorectal cancer patients were included after matching for age, sex and Duke’s stage. Factors associated with chemotherapy response rate and overall survival were evaluated by univariate Kaplan-Meier analyses or multivariate Cox regression model. Results: The overall response rates for mucinous and non-mucinous cancers were 33% and 58% (p=0.128), respectively. After adjusting for confounding factors, mucinous type was an independent factor to determine efficacy of chemotherapy (risk ratio, 0.15). The median overall survivals in mucinous and non-mucinous tumors were 8 months and 20 months, respectively (p=0.037). In multivariate analysis, mucinous histology was associated with poor prognosis (hazard ratio, 1.899, p=0.045). Conclusions: Metastatic mucinous colorectal cancers were less responsive to chemotherapy and had reduced survival in comparison to non-mucinous colorectal cancers. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。